Holding(s) in Company - Replacement

Spire Healthcare Group plc (the "Company")

25 August 2015

GENERAL TEXT AMENDMENT

The following amendments have been made to the 'TR-1: Notification of major interests in shares" announcement released on 24 August 2015 at 14.51 under RNS No 9078W.

2 Reason for notification - An acquisition or disposal of voting rights - Yes

7 Thresholds that are crossed or reached - Prior to transaction: below 3%, Subsequent to transaction: 29.9%

8A Voting rights attached to shares - Situation previous to triggering transaction - Number of shares - Nil

13 Additional information - The change in the indirect voting rights resulted from the acquisition by Mediclinic International Limited, through a wholly owned subsidiary Mediclinic Investments (Pty) Ltd of all the issued shares in Business Venture Investments No 1871 (Pty) Ltd, which in turn owns all the issued shares in Remgro Jersey Limited which company is a 29.9% shareholder of Spire Healthcare Group Plc.

All other details remain unchanged.

The full amended text is shown below.

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Spire Healthcare Group plc

2. Reason for the notification (please state Yes/No):

An acquisition or disposal of voting rights: YES

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:

An event changing the breakdown of voting rights: ( )

Other (please specify): 

3. Full name of person(s) subject to the notification obligation:

Mediclinic international limited

4. Full name of shareholder(s) (if different from 3.):

REMGRO JERSEY LIMITED

5. Date of the transaction (and date on which the threshold is crossed or reached if different): 24 August 2015

6. Date on which issuer notified: 24 August 2015 

7. Threshold(s) that is/are crossed or reached:

Prior to transaction: below 3% Subsequent to transaction: 29.9%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

1. Mediclinic International Limited (ultimate parent): indirect holding of 29.9% of voting rights in issuer.

2. Mediclinic Investments (Pty) Ltd (wholly owned subsidiary of Mediclinic International Limited): indirect holding of 29.9% of voting rights in issuer.

3. Business Venture Investments No 1871 (Pty) Ltd (wholly owned subsidiary of Mediclinic Investments (Pty) Ltd): indirect holding of 29.9% of voting rights in issuer.

4. Remgro Jersey Limited (wholly owned subsidiary of Business Venture Investments No 1871 (Pty) Ltd): direct holding of 29.9% of voting rights in issuer.

Proxy Voting:

10. Name of the proxy holder: N/A

11. Number of voting rights proxy holder will cease to hold: N/A

12. Date on which proxy holder will cease to hold voting rights: N/A

13. Additional information:

The change in the indirect voting rights resulted from the acquisition by Mediclinic International Limited, through a wholly owned subsidiary Mediclinic Investments (Pty) Ltd of all the issued shares in Business Venture Investments No 1871 (Pty) Ltd, which in turn owns all the issued shares in Remgro Jersey Limited which company is a 29.9% shareholder of Spire Healthcare Group Plc.

14. Contact name:

Anthony Dand, Interim Deputy Secretary, Spire Healthcare Group plc

15. Contact telephone number:

+ 44 (0)20 7427 9092